[1] 邓中甲. 方剂学[M].北京:中国中医药出版社,2003:2
DENG ZJ.Formulas of Chinese Medicine[M].Beijing:China Press of Traditional Chinese Medicine,2003:2
[2] 黄兴,李艳芬,寇冠军,等.补阳还五汤抗动脉粥样硬化作用机制研究进展[J].中华中医药杂志,2017,32(3):1187
HUANG X,LI YF,KOU GJ,et al.Research progress of mechanism of anti-atherosclerosis of Buyang Huanwu decoction[J].China J Tradit Chin Med Pharm,2017,32(3):1187
[3] 朱博冉,吴颢昕.补阳还五汤抗动脉粥样硬化机制的研究进展[J].中国动脉硬化杂志,2017,25(1):99
ZHU BR,WU HX.Research progress of Buyang Huanwu decoction on mechanism of anti-atherosclerosis[J].Chin J Arterioscler, 2017,25(1):99
[4] LIU EH,QI LW,CHENG XY,et al.Simultaneous determination of twelve bioactive constituents in Buyang Huanwu decoction by HPLC-DAD-ELSD and HPLC-TOF/MS[J].Biomed Chromatogr, 2010,24(2):125
[5] 王玎,王利胜,巴文强,等.HPLC 同时测定补阳还五汤提取液中4 种成分的含量[J].中国实验方剂学杂志,2015,21(9):46
WANG D,WANG LS,BA WQ,et al.Simultaneous determination of four components in Buyang Huanwu decoction extract by HPLC[J]. Chin J Exp Tradit Med Form,2015,21(9):46
[6] 叶肖栗,叶伟峰,张继业,等.HPLC 法测定补阳还五汤中主要成分及其代谢研究[J].药物分析杂志,2016,36(5):765
YE XL,YE WF,ZHANG JY,et al.Determination of main ingredients in Buyang Huanwu decoction by HPLC method and its metabolism study[J].Chin J Pharm Anal,2016,36(5):765
[7] 刘昌孝. 中药质量标志物(Q-marker):提高中药质量标准及质量控制理论和促进中药产业科学发展[J].中草药,2019,50(19):4517
LIU CX.Quality marker(Q-marker) of Chinese materia medica: improving quality standard and quality control theory of CMM and promoting scientific development of CMM industry[J].Chin Tradit Herb Drugs,2019,50(19):4517
[8] WANG S,WANG H,LU Y.Tianfoshen oral liquid:a CFDA approved clinical traditional Chinese medicine,normalizes major cellular pathways disordered during colorectal carcinogenesis[J]. Oncotarget,2017,8(9):14549
[9] 张娟,高英,李卫民.黄芪散中黄芪的质量控制[J].广东药学院学报,2014,30(6):717
ZHANG J,GAO Y,LI WM.Study on the quality standard of Astragali Radix from Huangqi powder[J].J Guangdong Pharm Univ,2014,30(6):717
[10] 包侠萍. 当归不同部位中阿魏酸的含量测定及炮制研究[J].海峡药学,2014,26(6):73
BAO XP.Determination and processing of ferulic acid in different parts of Angelica[J].Strait Pharm J,2014,26(6):73
[11] 严维花,曹虹虹,郭爽,等.当归不同炮制品的 UPLC 指纹图谱与多成分含量测定研究[J].中国中药杂志,2019,44(12):2499
YAN WH,CAO HH,GUO S,et al.UPLC fingerprint and multi- components content determination of different processed products of Angelica sinensis[J].China J Chin Mater Med,2019,44(12): 2499
[12] 李有琴. 川芎的质量控制方法研究[D].长沙:湖南师范大学,2019
LI YQ.Study on the Quality Control Method of Ligusticum chuanxiong[D].Changsha:Hunan Normal University,2019
[13] 陈冉,尹丹丹,杨沫,等.超高效液相色谱法比较鲜川芎和川芎药材中 6 种成分含量[J].安徽中医药大学学报,2019,38(6):84
CHEN R,YIN DD,YANG M,et al.Comparison of six active components between fresh and dried Rhizoma Ligustici Chuanxiong based on ultra-high-performance liquid chromatography[J].J Anhui Univ Tradit Chin Med,2019,38(6):84
[14] 朱美霞. 芍药苷和芍药内酯苷的含量测定及芍药苷和赤芍总苷在大鼠体内的代谢研究[D].沈阳:辽宁大学,2016
ZHU MX.Determination of Paeoniflorin and Albiflorin and Metabolism of Paeoniflorin and Total Paeony Glycosides in Rats [D].Shenyang:Liaoning University,2016
[15] 崔田,黄丽丹.桃仁、苦杏仁及其混伪品质量控制研究进展[J].中国药业,2014,23(8):86
CUI T,HUANG LD.Progress in quality control of peach kernel, bitter almond and their adulterants[J].China Pharm,2014,23(8): 86
[16] 李彤彤. 红花质量评价和不同花期成分变化研究[D].北京:北京中医药大学,2019
LI TT.Research on Quality Evaluation of Safflower and Changes of Compositions at Different Flowering Periods[D].Beijing:Beijing University of Chinese Medicine,2019
[17] 王煜. 冠心Ⅱ号主要吸收成分羟基红花黄色素 A 抗动脉粥样硬化的机理及相对贡献度研究[D].长沙:中南大学,2014
WANG Y.Research on Anti-atherosclerosis Mechanism and Relative Contribution of Hydroxysafflor yellow A in Guanxin II [D]. Changsha:Central South University,2014
[18] 孙继友. 芍药内酯苷对泡沫细胞及动脉粥样硬化形成的影响[D].长春:吉林大学,2017
SUN JY.Impact of Albiflorin on Formation of Foam Cells and Atherosclerosis[D].Changchun:Jilin University,2017
[19] 吴东方,靳善睿,刘娟,等.芍药苷抗ApoE 基因缺失小鼠动脉粥样硬化作用的初步研究[J].中国医院药学杂志,2015,35(5):385
WU DF,JIN SR,LIU J,et al.Primary study on the effect of paeoniflorin against experimental atherosclerosis in Apo E -/- mice[J].Chin J Hosp Pharm,2015,35(5):385
[20] QIN HW,LIU P,LIN SC,et al.Effects of astragaloside Ⅳ on the SDF-1/CXCR4 expression in atherosclerosis of Apo E-/- mice induced by hyperlipaemia[J].Evid Based Complement Alternat Med,2015,2015:385154
[21] DENG JG,CHUN Y,LI HL,et al.Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells[J].Biochem Biophys Res Commun, 2011,411(3):523
[22] YEH J,CINDROVA-DAVIES T,BELLERI M,et al.The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo[J].Angiogenesis,2011,14(2):187
[23] 王珅,方庆娟,武星,等.丁苯酞软胶囊对缺血性脑血管病患者颈动脉硬化的抗炎作用及斑块稳定性的影响[J].海南医学院学报,2017,23(7):946
WANG S,FANG QJ,WU X,et al.Effect of butylphthalide soft capsule on the anti-inflammatory effect and plaque stability in patients with ischemic cerebrovascular disease and carotid atherosclerosis[J].J Hainan Med Univ,2017,23(7):946
[24] 李玲. 藁本内酯对猪冠状动脉舒张作用机理探讨及药效学研究[D].兰州:兰州大学,2014.
LI L.Study on Porcine Coronary Vasodilatation Mechanism and Pharmacology of Ligustilide[D].Lanzhou:Lanzhou University, 2014
[25] 熊鸣,毕勇毅,张德玲,等.阿魏酸钠对高脂血症致动脉粥样硬化过程中胆固醇和甘油三酯代谢的影响[J].中国病理生理杂志,2008,24(9):1670
XIONG M,BI YY,ZHANG DL,et al.Effect of sodium ferulate on cholesterol and triglyceride metabolism in atherosclerosis with hyperlipidemia[J].Chin J Pathophysiol,2008,24(9): 1670
[26] ZHANG Y,REN P,KANG QF,et al.Effect of tetramethylpyrazine on atherosclerosis and SCAP/SREBP-1c signaling pathway in ApoE-/- ,mice fed with a high-fat diet[J].Evid Based Complement Alternat Med,2017,2017:3121989
[27] 洪远林,金玉青,姚艺新,等.HPLC-DAD-MS 检测川芎和日本川芎中的川芎嗪[J].中药材,2015,38(1):36
HONG YL,JIN YQ,YAO YX,et al.Assay of tetramethylpyrazine in Szechwan Lovage Rhizome and Cnidium Rhizome by HPLC-DAD- MS[J].J Chin Med Mater,2015,38(1):36
[28] 周永红,谢鸿,王天文,等.当归挥发油的提取与成分分析[J].化工技术与开发,2007,36(3):33
ZHOU YH,XIE H,WANG TW,et al.Extraction of volatile oil from Angelica and its chemical components analysis[J].Technol Dev Chem Ind,2007,36(3):33
[29] 韦小翠,杨书婷,张焱,等.2 种辅助方法提取川芎挥发油成分GC-MS分析[J].中成药,2019,41(1):129
WEI XC,YANG ST,ZHANG Y,et al.GC-MS analysis of two assistant methods on extracting volatile oil from Chuanxiong Rhizoma[J].Chin Tradit Pat Med,2019,41(1):129
